Bibliographies thématiques / Cerebrovascular disease

Littérature scientifique sur le sujet « Cerebrovascular disease »

Auteur : Grafiati
Publié le 4 juin 2021
Mis à jour le 3 mars 2023

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Sommaire

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Cerebrovascular disease ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Cerebrovascular disease"

1

Gorelick, Philip B. « Cerebrovascular Disease ». Nursing Clinics of North America 21, no 2 (juin 1986) : 275–88. http://dx.doi.org/10.1016/s0029-6465(22)00416-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Wolf, P. A., et J. C. Grotta. « Cerebrovascular Disease ». Circulation 102, Supplement 4 (14 novembre 2000) : IV—75—IV—80. http://dx.doi.org/10.1161/01.cir.102.suppl_4.iv-75.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Frost, Elizabeth A. M. « Cerebrovascular disease ». Current Opinion in Anaesthesiology 4, no 5 (octobre 1991) : 639–44. http://dx.doi.org/10.1097/00001503-199110000-00002.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Herrick, Ian A. « Cerebrovascular disease ». Current Opinion in Anaesthesiology 16, no 3 (juin 2003) : 337–42. http://dx.doi.org/10.1097/00001503-200306000-00016.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Caprio, Fan Z., et Farzaneh A. Sorond. « Cerebrovascular Disease ». Medical Clinics of North America 103, no 2 (mars 2019) : 295–308. http://dx.doi.org/10.1016/j.mcna.2018.10.001.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Holloway, R. G. « Cerebrovascular Disease ». Neurology 49, no 4 (1 octobre 1997) : 1192. http://dx.doi.org/10.1212/wnl.49.4.1192.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Sacco, Ralph L., et Tatjana Rundek. « Cerebrovascular disease ». Current Opinion in Neurology 25, no 1 (février 2012) : 1–4. http://dx.doi.org/10.1097/wco.0b013e32834f89b1.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Caplan, Louis R., D. Eric Searls et Fong Kwong Sonny Hon. « Cerebrovascular Disease ». Medical Clinics of North America 93, no 2 (mars 2009) : 353–69. http://dx.doi.org/10.1016/j.mcna.2008.09.004.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Bowsher, David, G. Vantrappen, David Mabey, Tom Treasure, KentL Woods, WilliamP Arend et David Bowsher. « CEREBROVASCULAR DISEASE ». Lancet 341, no 8838 (janvier 1993) : 156. http://dx.doi.org/10.1016/0140-6736(93)90015-9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Bonita, Ruth, et Robert Beaglehole. « CEREBROVASCULAR DISEASE ». Lancet 341, no 8859 (juin 1993) : 1510–11. http://dx.doi.org/10.1016/0140-6736(93)90640-3.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Thèses sur le sujet "Cerebrovascular disease"

1

Holt, Jim, et Gregg Mitchell. « Cerebrovascular Disease KSA ». Digital Commons @ East Tennessee State University, 2018. https://dc.etsu.edu/etsu-works/6458.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Murphy, Jeremy James. « Clinical trials in cerebrovascular disease ». Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293328.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Man, Lai-mei. « An exploratory study for the health seeking pattern of stroke survivors on alternative medicine ». Hong Kong : University of Hong Kong, 1998. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20133236.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Williams, David James. « Near infrared spectroscopy in cerebrovascular disease ». Thesis, University of Bath, 2002. https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426180.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Hoffmann, Tammy Coral. « Development and evaluation of a computer-generated individualised written education package for patients following stroke and their carers / ». [St. Lucia, Qld.], 2005. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18924.pdf.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Wan, Wai-kuen Christina. « An exploratory design of an empowerment group for the stroke survivors ». Hong Kong : University of Hong Kong, 1996. http://sunzi.lib.hku.hk/hkuto/record.jsp?B19469937.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Li, Sijian. « Evaluating the effectiveness of a stroke education programme in Wuhan City of China / ». Hong Kong : University of Hong Kong, 1999. http://sunzi.lib.hku.hk/hkuto/record.jsp?B20793224.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Fung, Mei-ling. « Stroke rehabilitation : predicting LOS and discharge placement / ». Hong Kong : University of Hong Kong, 2002. http://sunzi.lib.hku.hk/hkuto/record.jsp?B25101298.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Gibbs, Richard Geoffrey James. « The aetiology and epidemiology of cerebrovascular disease ». Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405270.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

Chan, Chi-wing Martin. « Is bilateral isokinematic training (BIT) more effective than unilateral limb training in improving the hemiplegic upper-limb function / ». View the Table of Contents & ; Abstract, 2004. http://sunzi.lib.hku.hk/hkuto/record/B30469697.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Livres sur le sujet "Cerebrovascular disease"

1

Vladimir, Hachinski, dir. Cerebrovascular disease. London : Baillière Tindall, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Hunt, Batjer H., dir. Cerebrovascular disease. Philadelphia : Lippincott-Raven, 1997.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

1924-, Kameyama Masakuni, Tomonaga Masanori et Aiba Tadashi, dir. Cerebrovascular disease. Tokyo : Igaku-Shoin, 1988.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

L, Babikian Viken, Wechsler Lawrence R et Higashida Randall T, dir. Imaging cerebrovascular disease. Philadelphia : Butterworth-Heinemann, 2003.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

S, Moore Wesley, dir. Surgery for cerebrovascular disease. 2e éd. Philadelphia : W.B. Saunders, 1996.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

B, Gorelick Philip, dir. Atlas of cerebrovascular disease. Philadelphia : Current Medicine, 1995.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

B, Gorelick Philip, et Sloan Michael A, dir. Atlas of cerebrovascular disease. 2e éd. Philadelphia : Current Medicine, 2002.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

J, Alberts Mark, dir. Genetics of cerebrovascular disease. Armonk, NY : Futura Pub. Co., 1999.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

S, Moore Wesley, dir. Surgery for cerebrovascular disease. New York : Churchill Livingstone, 1987.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

M, Sundt Thoralf, et Meyer Fredric B, dir. Sundt's Occlusive cerebrovascular disease. 2e éd. Philadelphia, PA : W.B. Saunders, 1994.

Trouver le texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Plus de sources

Chapitres de livres sur le sujet "Cerebrovascular disease"

1

Wagle, Kamal C. « Cerebrovascular Disease ». Dans Family Medicine, 837–49. Cham : Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_72.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Gerhard-Herman, Marie, et Aaron Aday. « Cerebrovascular Disease ». Dans Manual of Vascular Medicine, 63–72. Cham : Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-44715-1_7.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Roth, Elliot J. « Cerebrovascular Disease ». Dans Encyclopedia of Clinical Neuropsychology, 740–41. Cham : Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_2167.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
4

Patel, Sheela T., et K. Craig Kent. « Cerebrovascular Disease ». Dans Surgery, 1005–23. Berlin, Heidelberg : Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-57282-1_45.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
5

Roth, Elliot J. « Cerebrovascular Disease ». Dans Encyclopedia of Clinical Neuropsychology, 536. New York, NY : Springer New York, 2011. http://dx.doi.org/10.1007/978-0-387-79948-3_2167.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

McCabe, Melvina. « Cerebrovascular Disease ». Dans Family Medicine, 557–64. New York, NY : Springer New York, 1998. http://dx.doi.org/10.1007/978-1-4757-2947-4_65.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
7

Orsini, Donna L., Wilfred G. van Gorp et Kyle B. Boone. « Cerebrovascular Disease ». Dans The Neuropsychology Casebook, 40–68. New York, NY : Springer New York, 1988. http://dx.doi.org/10.1007/978-1-4612-3836-2_2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

Fowler, T. J., et R. W. May. « Cerebrovascular Disease ». Dans Neurology, 115–24. Dordrecht : Springer Netherlands, 1985. http://dx.doi.org/10.1007/978-94-010-9544-0_8.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Roth, Elliot J. « Cerebrovascular Disease ». Dans Encyclopedia of Clinical Neuropsychology, 1–2. Cham : Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-56782-2_2167-2.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
10

McCabe, Melvina L. « Cerebrovascular Disease ». Dans Family Medicine, 494–501. New York, NY : Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4757-4005-9_65.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Actes de conférences sur le sujet "Cerebrovascular disease"

1

Axelerad, Docu Any, Daniel Docu-Axelerad et Valentin Negrea. « Smoking and the Cerebrovascular Disease ». Dans DIALOGO-CONF 2018 OVERPOPULATION AND RELIGION's INVOLMENT (ORI). EDIS - Publishing Institution of the University of Zilina, Slovak Republic, 2018. http://dx.doi.org/10.18638/dialogo.2018.4.2.9.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Estévez, M., A. Argibay, L. Rodriguez, M. Freire, B. Gimena, J. Fernández-Martín et A. Rivera. « FRI0289 Cerebrovascular disease in the antiphospholipid syndrome ». Dans Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.4509.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
3

Gramasco, Hendrick Henrique Fernandes, Mateus Felipe dos Santos, Yasmim Nadime José Frigo, Guilherme Drumond Jardini Anastácio, Stella de Angelis Trivellato, Daniel Fabiano Barbosa dos Santos, Ana Cláudia Pires Carvalho et al. « Diverse clinical presentations of Moyamoya disease : a case series ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.530.

Texte intégral
Résumé :
Context: Moyamoya disease or chronic occlusive cerebrovascular disease is characterized by proximal occlusion of the internal carotid artery and its branches bilaterally, generating an angiographic “smoke” pattern (moyamoya, from Japanese “something hazy”) and by diverse ischemic manifestations. Case report: The sample consists of three female patients, aged between 13 and 46 years, followed in our service due to the diagnosis of Moyamoya Disease. Among the clinical manifestations presented, ischemic cerebrovascular events with neurological deficit predominated, and one of the patients presented two episodes compatible with stroke and one episode compatible with transient ischemic accident. The youngest patient presented with a choreic picture initially interpreted as Sydenham’s chorea. Although the gold standard for the diagnosis of chronic occlusive cerebrovascular disease is cerebral arterial angiography, it was possible to observe a pattern compatible with the disease in other modalities of examination, such as cerebral arterial angiotomography and cerebral arterial angioresonance. From the therapeutic point of view, one of the patients underwent surgical intervention (encephaloduromyosinangiosis), with improvement of symptoms after treatment. Conclusions: In this paper, we emphasize the importance of complementary imaging tests in the evaluation of patients with cerebrovascular syndromes and the diversity of clinical presentation of Moyamoya disease.
Styles APA, Harvard, Vancouver, ISO, etc.
4

Martins, Karine Felipe, Flávia Pascoal Teles, Amanda Fernandes de Sousa Oliveira Balestra et Isadora Rosa Maia. « Cerebrovascular diseases : the importance of recognizing them ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.188.

Texte intégral
Résumé :
Background: Until the 70s, cerebrovascular diseases (CVDs) were neglected to the lack of resources. However, due to the advancement of technology, several imaging tests have appeared, such as magnetic resonance and computed tomography, which facilitated the diagnosis and the understanding of the pathophysiology of each disease. Objectives: The objective of this work is to identify the main CVDs signs and symptoms. Methods: An integrative literature review was carried out based on selected articles from Google Scholar, PubMed and SciELO, using the terms headache, cerebrovascular disease, neurology. Results: CVDs are characterized by causing damage to brain vessels, due to changes in blood flow momentarily or permanently in an area of the brain, allowing them to be classified as ischemic or hemorrhagic. In ischemic there is a blockage of blood flow and, consequently, of oxygen to areas of the brain, in hemorrhagic rupture of a vessel occurs and, with this, blood leakage. Therefore, it is necessary to recognize the signs and symptoms early, in order to prevent loss of neurological function, movements on one side of the body and the presence or absence of headaches in both patients, with ischemic CVD and hemorrhagic CVD prevent rapid loss of consciousness accompanied by severe headache. Such signs and symptoms associated with the patient’s family history and lifestyle can help in the diagnosis of this disease. Conclusion: Therefore, it is important to recognize the signs and symptoms of CVDs, in order to determine the treatment and advise the patient, which will guarantee a better prognosis.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Qiang Sun, Qiang, Jiang Jiang Yuan et Lei Lei Zeng. « Interventional Therapy of Cerebrovascular Disease Mechanical Embolic Materials ». Dans 2015 International Conference on Mechanical Science and Engineering. Paris, France : Atlantis Press, 2016. http://dx.doi.org/10.2991/mse-15.2016.8.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
6

Oliveira, Francisco Gabriel Cabral, Juliana Paiva Ribeiro Moura, Matheus Henrique Oliveira et Mylena Teles de Jesus. « The relation between COVID-19 and cerebrovascular diseases ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.740.

Texte intégral
Résumé :
Introduction: Covid-19 is characterized by respiratory syndrome and has symptoms that affect the central nervous system such as headache, anosmia, hypercoagulability, etc. In this sense, it is known that the virus shows tropism by the receptors of the angiotensin-converting enzyme 2 (ACE2), becoming a gateway to the neurological system, which can cause complications. Is to relate the infection by COVID-19 and the increase in cerebrovascular diseases. Methods: A literature review was carried out using search for scientific articles in PubMed, in April / 2021, with a filter in the last 5 years, using the descriptors “Covid”, “Cerebrovascular Diseases” and “Man” associated with the Boolean operator AND. Results: 53 articles were found, of which 19 were selected for research. There is a higher frequency of neurological symptoms in patients with COVID-19 than in patients without the disease. The effect of binding the virus to ACE2 receptors is to activate a cascade of cytokines, which tends to lead to serious complications. For this reason, severe coagulopathies can be caused, increasing products of the degradation of C-reactive protein, D Dimer, fibrinogen and thrombocytopenia. The increase in cerebrovascular events also occurs because the antithrombotic, neuroprotective, antihypertensive effects, among others, of the alternative renin-angiotensin system in the brain are interrupted due to COVID-19. Conclusion: It was seen that cerebrovascular events are related to the course of COVID-19, in which patients may develop several serious complications, such as encephalitis, strokes and vascular thrombosis. Thus, the pathophysiology of this disease is related to an inflammatory process.
Styles APA, Harvard, Vancouver, ISO, etc.
7

Rahman, G. M. Mahmudur, H. Okazawa, Md Sherajul Islam, Md Shahjahan et S. S. Zakir. « Probing the neuronal status for cerebrovascular disease using EEG ». Dans 2017 International Conference on Electrical, Computer and Communication Engineering (ECCE). IEEE, 2017. http://dx.doi.org/10.1109/ecace.2017.7912926.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
8

SOSSI, VESNA. « PET for cerebrovascular diseases : status and limitation ». Dans Frontiers in Imaging Science : High Performance Nuclear Medicine Imagers for Vascular Disease Imaging (Brain and Heart). Trieste, Italy : Sissa Medialab, 2008. http://dx.doi.org/10.22323/1.039.0017.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
9

Mesquita, Rodrigo da Rosa, Tatiana Farias de Oliveira, Gibson Barros de Almeida Santana, Antônio Leopoldo do Nascimento Gama Albuquerque, Amanda Karine Barros Ferreira Rodrigues et Carlos Dornels Freire de Souza. « Epidemiological profile and temporal trend of mortality from cerebrovascular diseases in Northeast of Brazil, 1996-2016 ». Dans XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.600.

Texte intégral
Résumé :
Background: Cerebrovascular diseases represent the second leading cause of mortality in the world and Brazil occupies the leadership in the ranking of mortality in South America. Objectives: This study sought to analyze the sociodemographic profile and the time trend of the mortality rate from cerebrovascular disease in the Northeast of Brazil, 1996-2016. Methods: This is an ecological study of time series involving deaths from cerebrovascular diseases in the Northeastern of Brazil, 1996-2016. Sociodemographic variables (age, schooling, marital status, skin color, ICD category and federation units) were included and calculated crude and standardized mortality rates, according to gender and age group. A joinpoint regression model was applied for the temporal analysis, with a level of significance of 5%. Results: There were 490.433 deaths from cerebrovascular diseases in the Northeast of Brazil, 1996-2016. Of these deaths, 50,03% (n = 245.354) were women, 79,72% (n = 390.957) elderly, 46,66% (n = 228.851) brown, 51,81% (n = 332.439) illiterate and 37,93% (n = 186.014) were married. Of the causes of death, 56,63% (n = 277.741) resulted from stroke, not specified as hemorrhagic or ischemic (I64). In the Northeast, there was a predominance of the elderly population, with growth of 1.2% (p < 0.001). Conclusions: Standardized mortality increased in four states, being higher in Maranhão and Piauí, with a predominance of females and age equal to or above 60 years.
Styles APA, Harvard, Vancouver, ISO, etc.
10

Mou, Xiao, Xingce Wang, Zhongke Wu, Xuesong Wang et Mingquan Zhou. « An automatic eHealth platform for cardiovascular and cerebrovascular disease detection ». Dans 2015 International Symposium on Bioelectronics and Bioinformatics (ISBB). IEEE, 2015. http://dx.doi.org/10.1109/isbb.2015.7344924.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.

Rapports d'organisations sur le sujet "Cerebrovascular disease"

1

Chen, Qian, et Qinhao Wang. The neuroprotective effect of edaravone dexborneol in cerebrovascular disease : a comprehensive systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, novembre 2022. http://dx.doi.org/10.37766/inplasy2022.11.0069.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
2

Roldán-González, Elizabeth, Carolina Robledo-Castro, Piedad Rocío Lerma-Castaño et María Luisa Hurtado-Otero. Validity and reliability of the Wolf Motor Function Test -WMFT in patients with Cerebrovascular disease : Scoping review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, octobre 2022. http://dx.doi.org/10.37766/inplasy2022.10.0044.

Texte intégral
Résumé :
Review question / Objective: This scoping review aimed to compile the studies that have examined the validity and reliability of the different versions of the Wolf Motor Function Test - WMFT in patients with Cerebrovascular disease. Background: Numerous investigations in rehabilitation have used the WMFT as an instrument for the primary measurement of the results; however, to date, there are no known reviews that have compiled the reliability and validity of the wolf test in its different versions, which is considered of vital importance and constitutes critical information for decision making in the process of evaluation and follow-up of patients with stroke in clinical, academic and research environments.
Styles APA, Harvard, Vancouver, ISO, etc.
3

Hu, XinYi, JingXuan Hao et HangYue Wang. Improvement of Environmental enrichment on Cognitive Functions in Patients and animals : A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, décembre 2022. http://dx.doi.org/10.37766/inplasy2022.12.0014.

Texte intégral
Résumé :
Review question / Objective: To study the relationship between environmental enrichment and cognitive function through a meta-analysis of the literature, analyze its effects on the improvement of cognitive function in patients and animals, and evaluate the effects of different environmental enrichment measures on cognitive function improvement. Condition being studied: Cognitive decline refers to an individual's memory, language, reasoning and other aspects of cognitive function showing obvious, measurable decline or abnormal. The causes of cognitive decline are various, including neurodegeneration, cerebrovascular disease, infection, trauma, and depression. Alzheimer's disease and stroke are the most common.
Styles APA, Harvard, Vancouver, ISO, etc.
4

LI, Peng, et Junjun Liu. Effect of statin therapy on moderate-to-severe depression : an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, mars 2022. http://dx.doi.org/10.37766/inplasy2022.3.0016.

Texte intégral
Résumé :
Review question / Objective: We aim to assess the antidepressant effects of statin therapy among patients complicated with moderate to severe depression. Condition being studied: Depression is one of the major causes of disability worldwide, and major depressive disorders (MDD) contribute to a significant heavy disease burden, which is expected to be second by 2050, only to heart disease. Despite great improvement in therapy, the treatment efficacy remains low. Therefore, alternative therapies have been intensely investigated. A substantial body of researches have suggested that inflammation is one of the operative pathways between MDD and increased risk of somatic comorbidities, and some specific depressive symptoms. Depression occurs in most patients with cardiac and cerebrovascular disease due to the long-term effects, and depression increases the risk of cardiovascular disease in the population as a whole and in patients with coronary artery disease or stroke. Several observational studies have demonstrated reduced rates of depression among patients taking statins, which may be related to its anti-inflammatory effect. However, whether statin improves the depressive symptoms and its associated mechanism is still mixed. Furthermore, there is little evidence about statin treatment effect in those with moderate to severe depression. In addition, whether the effect of statin treatment on depressive symptom changes with time or is affected by baseline depression severity or percentage change of lipid levels has not been explored in previous studies.
Styles APA, Harvard, Vancouver, ISO, etc.
5

Li, Tian, Shanshan Jin, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin et al. Metformin may reduce the mortality and cardiac events in patients with cardio-cerebrovascular diseases, irrespective of concurrent diabetes : a meta-analysis of randomized controlled trails and cohort studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, juin 2020. http://dx.doi.org/10.37766/inplasy2020.6.0008.

Texte intégral
Styles APA, Harvard, Vancouver, ISO, etc.
Vous pouvez également être intéressé par les bibliographies sur le sujet « Cerebrovascular disease » pour d’autres types de sources :
Articles de revues Thèses Livres
Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!

Vers la bibliographie